Synairgen (SNG)

 38.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 52.00
  • 52 Week Low: 17.50
  • Currency: UK Pounds
  • Shares Issued: 69.56m
  • Volume: 3,636
  • Market Cap: £26.78m
  • RiskGrade: 343
  • Beta: 0.33

Latest ShareCast News

Synairgen no wheeze as asthma drug trial boosts shares

Date: Thursday 19 Apr 2012

Southampton based research firm, Synairgen, has rocketed in morning trading after announcing results for a treatment which could protect asthmatics from respiratory virus infections.

Synairgen Regulatory News

Professor Stephen Holgate given prestigious Award 22-May-2012 07:30 RNS-R
Holding(s) in Company 01-May-2012 12:55 RNS
Positive Phase II asthma data 19-Apr-2012 07:00 RNS
Notice of Report and Accounts 02-Mar-2012 07:00 RNS
Preliminary results 01-Feb-2012 07:00 RNS

Synairgen Newspaper Links

No recent information was found.

Synairgen News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Synairgen Market Data

Currency UK Pounds
Share Price 38.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 52.00
52 Week Low 17.50
Volume 3,636
Shares Issued 69.56m
Market Cap £26.78m
Beta 0.33
RiskGrade 343

Synairgen Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
87.13% above the market average87.13% above the market average87.13% above the market average87.13% above the market average87.13% above the market average
67.86% above the sector average67.86% above the sector average67.86% above the sector average67.86% above the sector average67.86% above the sector average
Income Not Available
Growth Not Available

Synairgen Dividends

No dividends found

Trades for 25-May-2012

Time Volume / Share Price
16:29 3,636 @ 36.00p

Synairgen Key Personnel

CEO Richard J Marsden
Finance Director John C Ward

Top of Page